4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-368285
Chief Executive Officer sold 18,921 shares at $49.57 ($937,957)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham Chief Executive Officer | 2026-08-25 | Sale 10b5-1 | −18,921 | $49.57 | $937,957 | 467,187 | D |
| Open-market sales · 18,921 sh · avg $49.57 · $937,957 | |||||||
Loading xslF345X06/ownership.xml…